Health TrialsbyHealthPanel

Meditative Neurofeedback for Depression

ConditionsDepression - Major Depressive DisorderDepression Disorders
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of California, San Diego

About this trial

The goal of this open-label single-arm study is to test a meditative neurofeedback intervention for depressed mood.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

moderate depression per PHQ9 symptom ratings

Disqualifiers

active substance abuse/dependence

psychotic disorders

bipolar disorder

displaying acutely suicidal behaviors

Trial design

Design model

Single group

Treatments tested in this trial

  • MediNF

    Behavioral

    Over 10-sessions participants will engage in a breath-focused meditative practice with frontal brain connectivity neurofeedback provided to enhance performance.

Treatment groups

27 Participants
are divided into 1 treatment group
Group A: MediNFExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

PHQ9

Depression Symptoms on the Patient Health Questionnaire 9-item (PHQ9) scale, min 0 max 27 with lower scores representing better outcome

Time frame
8 weeks

Secondary outcomes

1

MAAS

Mindfulness on the Mindful Attention Awareness Scale (MAAS), min 6 max 84 with higher scores representing better outcome

Time frame
8 weeks
2

RRQ

Rumination on the Ruminative Response Questionnaire (RRQ) scale, min 22 max 88 with lower scores representing better outcome

Time frame
8 weeks
3

GAD7

Anxiety symptoms on the Generalized Anxiety Disorder 7-item (GAD7) scale, min 0 max 21 with lower scores representing better outcome

Time frame
8 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of California, San Diego

Lead sponsor

Source ClinicalTrials.gov
Apply now